Yaku H, Shah SJ. The Key Role of Diagnostic Imaging in Early HFpEF. JACC Cardiovasc Imaging. 2025, Jul 17:S1936-878X(25)00306-7.
Kitai T, Kohsaka S, Kato T, Kato E, Sato K, Teramoto K, Yaku H, Akiyama E, Ando M, Izumi C, Ide T, Iwasaki YK, Ohno Y, Okumura T, Ozasa N, Kaji S, Kashimura T, Kitaoka H, Kinugasa Y, Kinugawa S, Toda K, Nagai T, Nakamura M, Hikoso S, Minamisawa M, Wakasa S, Anchi Y, Oishi S, Okada A, Obokata M, Kagiyama N, Kato NP, Kohno T, Sato T, Shiraishi Y, Tamaki Y, Tamura Y, Nagao K, Nagatomo Y, Nakamura N, Nochioka K, Nomura A, Nomura S, Horiuchi Y, Mizuno A, Murai R, Inomata T, Kuwahara K, Sakata Y, Tsutsui H, Kinugawa K; Japanese Circulation Society and the Japanese Heart Failure Society Joint Working Group. JCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure. J Card Fail. 2025 Mar 27:S1071-9164(25)00100-9.
Yaku H, Fudim M, Shah SJ. Role of Splanchnic Circulation in the Pathogenesis of Heart Failure. J Cardiol. 2024;83(5):330-337.
Wattanachayakul P, Kittipibul V, Salah HM, Yaku H, Gustafsson F, Baratto C, Caravita S, Fudim M. Invasive haemodynamic assessment in heart failure with preserved ejection fraction. ESC Heart Failure 2024 Nov 8.
Wattanachayakul P, Kittipibul V, Salah HM, Yaku H, Nuñez J, De la Espriella R, Biering-Sørensen T, Fudim M. Non-invasive heart failure monitoring: leveraging smart scales and digital biomarkers to improve heart failure outcomes. Heart Fail Rev. 2024 Sep;29(5):1145-1156.
Yaku H, Shah SJ. Targeted Therapeutics for Left Atrial Myopathy in Heart Failure with Preserved Ejection Fraction. SHINZO J. 2024;56(2):185-194.
Yaku H, Kaneda K, Kitamura J, Kato T, Kimura T. Kampo medicine for the holistic approach to older adults with heart failure. J Cardiol. 2022 Oct;80(4):306-312.
Hidenori Yaku, MD, PhD/ 夜久 英憲
〒564-8565 大阪府吹田市岸部新町6番1号
E-mail: hide.yaku[at]ncvc.go.jp